Khamraev Atadjan
- Effectiveness of the WHO regimen for treatment of multidrug resistant tuberculosis (MDR-TB)By Maryline Bonnet, Mathieu Bastard, Philipp Du Cros, Khamraev Atadjan, Kamene Kimenye, Shazina Khurkhumal, Armen Hayrapetyan, Alex Telnov, Cathy Hewison and Francis VaraineMaryline Bonnet1Clinical Research Department, Epicentre, Paris, FranceMathieu Bastard1Clinical Research Department, Epicentre, Paris, FrancePhilipp Du Cros2Manson Unit, Médecins Sans Frontières, London, United KingdomKhamraev Atadjan3Tuberculosis Program, Ministry of Health Karakalpakstan, Nukus, Karakalpakstan, UzbekistanKamene Kimenye4Coordinator of Programmatic Management of Drug Resistant Tuberculosis, Division of Leprosy, Tuberculosis and Lung Disease, Nairobi, KenyaShazina Khurkhumal5Coordinator, Abkhazian National Tuberculosis Program, Soukumi, Abkhazia, GeorgiaArmen Hayrapetyan6Director, Amenian National Tuberculosis Program, Yerevan, ArmeniaAlex Telnov7Medical Department, Médecins Sans Frontières, Geneva, SwitzerlandCathy Hewison8Medical Department, Médecins Sans Fronitères, Paris, FranceFrancis Varaine9Tuberculosis Working Group, Médecins Sans Frontières, Paris, France
Buying books on this site
Purchases made on this website are of electronic books only.
About the ERS books
The ERS Monograph is the quarterly book series from the European Respiratory Society. Each Monograph covers a specific area of respiratory medicine, providing in-depth reviews that give clinicians at all levels a concise, comprehensive guide to symptoms, diagnosis and treatment.
The ERS Handbooks are compact guides to broad areas of the respiratory field. Launched in 2010, the series now covers adult, paediatric and sleep respiratory medicine, includes a companion volume of self-assessment questions and features the ERS Practical Handbooks.